What is Close Concerns?
Operating as a specialized industry information service, Close Concerns provides essential intelligence regarding the diabetes ecosystem, pre-diabetes, obesity, and broader cardio-metabolic health. Through its flagship service, Closer Look, the company delivers rigorous reporting on clinical trial outcomes, regulatory shifts, and evolving market dynamics. By bridging the gap between complex medical data and actionable insights, the firm serves as a vital resource for manufacturers, clinicians, and healthcare systems striving to improve patient outcomes. Its unique foundation, rooted in lived experience with diabetes, ensures that its research remains both clinically relevant and patient-centric, maintaining a high standard of excellence in a rapidly changing healthcare environment.
How much funding has Close Concerns raised?
Close Concerns has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Close Concerns
PPP
Public-Private Partnership
What's next for Close Concerns?
With this late-stage funding, Close Concerns is strategically positioned to scale its operations and enhance its digital infrastructure. The company is expected to prioritize the expansion of its research team and the integration of advanced data analytics to better serve its growing subscriber base. As the demand for high-fidelity intelligence in the cardio-metabolic space continues to rise, the firm will likely focus on broadening its coverage of emerging therapies and digital health interventions. This growth trajectory underscores the company's commitment to driving innovation and supporting the stakeholders who are fundamentally transforming the standard of care for individuals living with Type 1 and Type 2 diabetes.
See full Close Concerns company page
